FDA Approved: GEMFIBROZIL — Supplemental Application (Chartwell RX, LLC)

View source ↗

Summary

This document indicates FDA approval of a supplemental ANDA for Gemfibrozil from Chartwell RX, LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperlipidemia
• Hypertriglyceridemia

Drugs mentioned

• Gemfibrozil (Gemfibrozil)

Snippet

SUPPL AP for GEMFIBROZIL (GEMFIBROZIL)